You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 2, September 1945 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PENICILLIN IN THE TREATMENT OF CHRONIC OSTEOMYELITIS

A PRELIMINARY REPORT

JOSEPH BUCHMAN, M.D.; JOHN E. BLAIR, Ph.D.

Arch Surg. 1945;51(2):81-92.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The history of the treatment of chronic osteomyelitis is replete with many rebuffs to the suffering victims, despite the application of many new procedures and drugs and serums which have been developed in recent decades. Notwithstanding the fact that these new approaches have produced spectacular results in the treatment of other types of infections, they have been found wanting in the treatment of chronic osteomyelitis. These failures are due to the inherent nature of the chronic osteomyelitic lesion. Many hopes, raised high with the advent of every new therapeutic agent, have met with disappointment due to the lack of appreciation of the differences existing between the chronic osteomyelitic lesion and other lesions and the specialized problems involved in the cure of the disease under consideration

Rational therapy can be administered only when the pathologic character of the involvement is appreciated. Briefly, the chronic osteomyelitic lesion presents a diseased bone which . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Hospital for Joint Diseases.


Footnotes

The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Hospital for Joint Diseases. The penicillin was provided by the Office of Scientific Research and Development from supplies assigned by the Committee on Medical Research for clinical investigations recommended by the Committee on Chemotherapeutics and Other Agents of the National Research Council.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1945 American Medical Association. All Rights Reserved.